Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Jan. 31, 2017
Mar. 13, 2017
Document And Entity Information [Abstract]    
Entity Registrant Name PharmaCyte Biotech, Inc.  
Entity Central Index Key 0001157075  
Document Type 10-Q  
Document Period End Date Jan. 31, 2017  
Amendment Flag false  
Current Fiscal Year End Date --04-30  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   875,308,610
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2017  
Entity Current Reporting Status Yes  
Entity Well Known Seasoned Issuer No  
Entity Voluntary Filers No